Abstract
A corrigendum on Melatonin Protects MCAO-Induced Neuronal Loss via NR2A Mediated Prosurvival Pathways by Shah FA, Liu G, Al Kury LT, Zeb A, Koh P-O, Abbas M, Li T, Yang X, Liu F, Jiang Y and Li S (2019). Front. Pharmacol. 10:297. doi: 10.3389/fphar.2019.00297 Phil-Ok Koh was not included as an author in the published article. The corrected Author Contributions Statement appears below. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
| Original language | English |
|---|---|
| Article number | 702 |
| Journal | Frontiers in Pharmacology |
| Volume | 10 |
| Issue number | JUN |
| DOIs |
|
| State | Published - 2019 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- AMPA receptor
- Ischemic stroke
- Melatonin
- NMDA receptor
- PI3K/AKT/GSK3 pathway
Fingerprint
Dive into the research topics of 'Erratum: MCAO-induced neuronal loss via NR2A mediated prosurvival pathways(Front. Pharmacol. (2019) 10 (297), 10.3389/fphar.2019.00297)'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver